Venous thromboembolism after high-dose chemotherapy in a patient with Hodgkin's lymphoma receiving the new oral contraceptive ethinylestradiol and drospirenone ("Yasmine")

Bone Marrow Transplant. 2005 Jan;35(1):103. doi: 10.1038/sj.bmt.1704725.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Androstenes / adverse effects*
  • Angiography
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carmustine / therapeutic use
  • Contraceptives, Oral, Synthetic / adverse effects
  • Cytarabine / therapeutic use
  • Etoposide / therapeutic use
  • Female
  • Hodgkin Disease / drug therapy*
  • Humans
  • Immunotherapy / methods*
  • International Normalized Ratio
  • Lynestrenol / adverse effects*
  • Melphalan / therapeutic use
  • Mineralocorticoid Receptor Antagonists / adverse effects
  • Risk
  • Risk Factors
  • Time Factors
  • Venous Thrombosis / etiology*
  • Warfarin / adverse effects

Substances

  • Androstenes
  • Contraceptives, Oral, Synthetic
  • Mineralocorticoid Receptor Antagonists
  • Cytarabine
  • Warfarin
  • Etoposide
  • drospirenone
  • Lynestrenol
  • Melphalan
  • Carmustine

Supplementary concepts

  • BEAM regimen